Investor Type | Firm |
Industries | BioTech • Material Science • Medical Devices (& Hospital Services) • DeepTech |
Stages | Pre-Seed, Seed, Series A |
Investing | United States |
Investment Range | $400,000 - $400,000 |
Investment Sweet Spot | $400,000 |
SciFounders is an investment fund committed to fostering innovation in the areas of BioTech, Material Science, Medical Devices (& Hospital Services), and DeepTech. It is a specialist boutique fund that focuses on founder-led companies that are in the early stages of development, primarily at the Pre-Seed, Seed, and Series A stages. SciFounders is distinguished by its unique investment approach, marrying Silicon Valley mindset with biotech investing. This means prioritizing technology development at a company's core and supporting technical founders who can evolve into effective business leaders akin to the examples set by Regeneron and Genentech. The fund is involved in diverse investment opportunities, seeking bold, innovative solutions that have the potential to scale into multi-billion dollar businesses. With an investment sweet spot of $400,000, SciFounders provides not just financial support but also mentorship and access to a valuable network, easing the transition for technical founders into leadership roles. The fund's CEO, Matt Krisiloff, offers comprehensive insights on effective storytelling to captivate a range of investors, the importance of understanding the competitive landscape, and strategies for running an effective fundraising process. SciFounders encourages founder-led fundraising efforts, emphasizing the importance of choosing the right partners who are patient, share the company's vision, and can contribute positively to the company's trajectory. While equity investment is at the core of their strategy, SciFounders is also aware of the benefit of non-dilutive capital sources and promotes exploration of government grants, private funding, and strategic partnerships. Matt Krisiloff is a proponent of scientists in industry considering entrepreneurship, particularly given his perspective on the current financial market conditions and the personality traits that scientists from industry may bring to a startup environment. The firm is actively engaged in supporting founders coming from academic backgrounds, recognizing the unique advantages of industry experience and the effectiveness of companies as social coordination tools for tackling hard problems.